NO20074933L - Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat - Google Patents

Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat

Info

Publication number: NO20074933L
Authority: NO; Norway
Prior art keywords: pharmaceutical composition; indolylmaleimide derivative; indolylmaleimide; derivative; pharmaceutical compositions
Prior art date: 2005-03-01

Application number

NO20074933A

Other languages

English (en)

Norwegian (no)

Inventor

Patrice Guitard

Marie-Christine Wolf

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-01

Filing date

2007-09-28

Publication date

2007-09-28

2007-09-28 Application filed by Novartis Ag filed Critical Novartis Ag

2007-09-28 Publication of NO20074933L publication Critical patent/NO20074933L/no

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 3
WIQRSJOCVVPMPS-UHFFFAOYSA-N 3-(1h-indol-2-yl)pyrrole-2,5-dione Chemical class O=C1NC(=O)C(C=2NC3=CC=CC=C3C=2)=C1 WIQRSJOCVVPMPS-UHFFFAOYSA-N 0.000 title abstract 2
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)

NO20074933A 2005-03-01 2007-09-28 Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat NO20074933L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0504203.1A GB0504203D0 (en)	2005-03-01	2005-03-01	Organic compounds
PCT/EP2006/001767 WO2006092255A1 (en)	2005-03-01	2006-02-27	Pharmaceutical composition comprising an indolylmaleimide derivative

Publications (1)

Publication Number	Publication Date
NO20074933L true NO20074933L (no)	2007-09-28

Family

ID=34430431

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20074933A NO20074933L (no)	2005-03-01	2007-09-28	Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat

Country Status (21)

Country	Link
US (1)	US20080187582A1 (pt)
EP (1)	EP1855667A1 (pt)
JP (1)	JP2008531625A (pt)
KR (2)	KR20070099049A (pt)
CN (1)	CN101132792A (pt)
AR (1)	AR054231A1 (pt)
AU (1)	AU2006220056B2 (pt)
BR (1)	BRPI0607413A2 (pt)
CA (1)	CA2599196A1 (pt)
GB (1)	GB0504203D0 (pt)
GT (1)	GT200600072A (pt)
IL (1)	IL184847A0 (pt)
MA (1)	MA29278B1 (pt)
MX (1)	MX2007010559A (pt)
NO (1)	NO20074933L (pt)
PE (1)	PE20061243A1 (pt)
RU (1)	RU2007136162A (pt)
TN (1)	TNSN07337A1 (pt)
TW (1)	TW200700062A (pt)
WO (1)	WO2006092255A1 (pt)
ZA (1)	ZA200706192B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI320783B (en)	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
GB0613162D0 (en) *	2006-06-30	2006-08-09	Novartis Ag	Organic compounds
KR20090042926A (ko) *	2006-08-23	2009-05-04	노파르티스 아게	안 질환에 있어서의 ｐｋｃ 억제제, 특히 인돌릴말레이미드유도체의 용도
MX2009004048A (es) *	2006-10-20	2009-04-27	Novartis Ag	Modificaciones de cristal de la 3-(1h-indol-3-il)-4-[2-(4-metil-pi perazin-1-il)-quinazolin-4-il]-pirrol-2,5-diona.
US20100075997A1 (en) *	2006-12-07	2010-03-25	Alexander Korn	Use of pkc inhibitors in transplantation
WO2008112479A1 (en) *	2007-03-09	2008-09-18	Novartis Ag	Salts of 3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl] -pyrrole-2, 5-di one
PE20091522A1 (es) *	2007-12-21	2009-10-29	Novartis Ag	Composicion farmaceutica solida que contiene 3-(1.h-indol-3-il)-4-[2-(4-metil-piperazin-1-il)-quinazolin-4-il]-quinazolin-4-il]-pirrol-2,5-diona
DE102008047910A1 (de)	2008-09-19	2010-03-25	Molkerei Meggle Wasserburg Gmbh & Co. Kg	Tablettierhilfsstoff auf Laktose- und Cellulosebasis
UY33472A (es) *	2010-06-30	2012-01-31	Novartis Ag	?composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1hbencimidazol-2-il]-1h-quinolin-2-ona?.
JO3753B1 (ar) *	2011-10-14	2021-01-31	Otsuka Pharma Co Ltd	قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
CN109846840B (zh) *	2018-12-18	2021-08-10	江西润泽药业有限公司	一种血管内皮生长因子抑制剂的固体剂型及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2237221C (en) *	1995-11-20	2003-03-25	Eli Lilly And Company	Protein kinase c inhibitor
EP1224932A4 (en) *	1999-08-20	2002-10-16	Sagami Chem Res	ACTIVE SUBSTANCES TO INHIBIT CELL DEATH
SG159378A1 (en) *	2000-11-07	2010-03-30	Novartis Ag	Indolylmaleimide derivatives as protein kinase c inhibitors
PE20040079A1 (es) *	2002-04-03	2004-04-19	Novartis Ag	Derivados de indolilmaleimida

2005
- 2005-03-01 GB GBGB0504203.1A patent/GB0504203D0/en not_active Ceased
2006
- 2006-02-15 GT GT200600072A patent/GT200600072A/es unknown
- 2006-02-24 PE PE2006000222A patent/PE20061243A1/es not_active Application Discontinuation
- 2006-02-27 WO PCT/EP2006/001767 patent/WO2006092255A1/en not_active Ceased
- 2006-02-27 KR KR1020077019720A patent/KR20070099049A/ko not_active Ceased
- 2006-02-27 EP EP06707282A patent/EP1855667A1/en not_active Withdrawn
- 2006-02-27 CN CNA2006800066977A patent/CN101132792A/zh active Pending
- 2006-02-27 TW TW095106715A patent/TW200700062A/zh unknown
- 2006-02-27 JP JP2007557400A patent/JP2008531625A/ja active Pending
- 2006-02-27 KR KR1020097018247A patent/KR20090097224A/ko not_active Withdrawn
- 2006-02-27 AR AR20060100713A patent/AR054231A1/es not_active Application Discontinuation
- 2006-02-27 RU RU2007136162/15A patent/RU2007136162A/ru not_active Application Discontinuation
- 2006-02-27 US US11/815,865 patent/US20080187582A1/en not_active Abandoned
- 2006-02-27 AU AU2006220056A patent/AU2006220056B2/en not_active Ceased
- 2006-02-27 CA CA002599196A patent/CA2599196A1/en not_active Abandoned
- 2006-02-27 MX MX2007010559A patent/MX2007010559A/es not_active Application Discontinuation
- 2006-02-27 BR BRPI0607413-8A patent/BRPI0607413A2/pt not_active IP Right Cessation
2007
- 2007-07-26 IL IL184847A patent/IL184847A0/en unknown
- 2007-07-26 ZA ZA200706192A patent/ZA200706192B/en unknown
- 2007-08-31 TN TNP2007000337A patent/TNSN07337A1/en unknown
- 2007-08-31 MA MA30179A patent/MA29278B1/fr unknown
- 2007-09-28 NO NO20074933A patent/NO20074933L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20090097224A (ko)	2009-09-15
AU2006220056B2 (en)	2009-12-10
CN101132792A (zh)	2008-02-27
CA2599196A1 (en)	2006-09-08
JP2008531625A (ja)	2008-08-14
EP1855667A1 (en)	2007-11-21
GB0504203D0 (en)	2005-04-06
KR20070099049A (ko)	2007-10-08
US20080187582A1 (en)	2008-08-07
TNSN07337A1 (en)	2008-12-31
PE20061243A1 (es)	2006-12-21
RU2007136162A (ru)	2009-04-10
ZA200706192B (en)	2008-07-30
BRPI0607413A2 (pt)	2009-09-01
WO2006092255A1 (en)	2006-09-08
GT200600072A (es)	2006-10-09
MX2007010559A (es)	2007-10-03
TW200700062A (en)	2007-01-01
AU2006220056A1 (en)	2006-09-08
MA29278B1 (fr)	2008-02-01
AR054231A1 (es)	2007-06-13
IL184847A0 (en)	2007-12-03

Legal Events

Date	Code	Title	Description
2011-09-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20084752L (no)	2008-12-17	Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse
BRPI0821004A8 (pt)	2017-12-26	Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste
TNSN07337A1 (en)	2008-12-31	Pharmaceutical composition comprising an indolylmaleimide derivative
UA94942C2 (ru)	2011-06-25	Фармацевтические композиции с ингибиторами dpp iv
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
MA32200B1 (fr)	2011-04-01	Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
DK2024352T3 (da)	2013-05-27	Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling
WO2008049116A3 (en)	2008-06-05	Substituted indoles
NO20064041L (no)	2006-09-08	Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NO20062504L (no)	2006-07-21	Sammensetninger og doseringsformer for forbedret absorpsjon
WO2007092620A3 (en)	2009-03-26	Stable formulations, and methods of their preparation and use
NO20043367L (no)	2004-08-13	Oralt farmasoytisk preparat
WO2007090882A3 (en)	2007-12-13	Pharmaceutical extended release compositions comprising pramipexole
NO20061245L (no)	2006-05-31	Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en bisfosfon
WO2008087367A3 (fr)	2008-11-06	Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
CY1109962T1 (el)	2014-09-10	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
ZA200801575B (en)	2008-12-31	Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily
WO2008006795A3 (en)	2008-03-06	Indole compounds
NO20082047L (no)	2008-04-29	Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
NI201100227A (es)	2012-03-28	Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica.
DK1511489T3 (da)	2011-05-02	Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A
WO2009032843A3 (en)	2009-04-23	Deuterated ethambutols and their use
WO2008081829A1 (ja)	2008-07-10	難水溶性薬物の溶解性維持用アミノアルキルメタアクリレートコポリマーｅ
UY30424A1 (es)	2008-01-31	Derivados de quinolina, su preparacion, su uso y medicamentos que comprenden los mismos.
WO2006077024A3 (en)	2006-09-08	5-aminoindole derivatives